Ad-hoc | 20 September 2016 18:04


Jenoptik AG: Jenoptik President & CEO Dr. Michael Mertin will not extend his employment contract as a member of the Executive Board of JENOPTIK AG.

Jenoptik AG  / Key word(s): Change of Personnel

20.09.2016 18:04

Disclosure of an inside information according to Article 17 MAR,
transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

The President & CEO Dr. Michael Mertin has today informed the Supervisory
Board that he will not be seeking another term on the Executive Board after
the expiry of his employment contract on June 30, 2017. After the
termination of his current contract Dr. Mertin will concentrate on new
challenges outside Jenoptik. The Supervisory Board thanks Dr. Mertin for
his successful work.

The Supervisory Board will now focus on the succession to Dr. Mertin and
for that purpose will start a structured process.

Contact:
Thomas Fritsche
JENOPTIK AG
Head of Investor Relations
Phone / Fax: 03641-652291 / 2804
thomas.fritsche@jenoptik.com


20.09.2016 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Jenoptik AG
              Carl-Zeiss-Straße 1
              07743 Jena
              Germany
Phone:        +49 (0)364 165-0
Fax:          +49 (0)364 165-2804
E-mail:       ir@jenoptik.com
Internet:     www.jenoptik.com
ISIN:         DE0006229107
WKN:          622910
Indices:      TecDAX
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated
              Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
              Stuttgart, Tradegate Exchange
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------